未登录Ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2-early breast cancer: final invasive disease-free survival (iDFS) analysis from the NATALEE trial
Hortobagyi, Gabriel; Stroyakovsky, Daniil; Yardley, Denise; Huang, Chiun-Shen; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Parnizari, Federico; Ghaznawi, Farhat; Li, Zheng; Waters, Sorcha; Chakravartty, Arunava; Slamon, Dennis .png)
分享.png)
收藏Ribociclib plus Endocrine Therapy in Early Breast CancerSlamon, Dennis; Lipatov, Oleg; Nowecki, Zbigniew; McAndrew, Nicholas; Kukielka-Budny, Bozena; Stroyakovskiy, Daniil; Yardley, Denise A.; Huang, Chiun-Sheng; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Ruiz-Borrego, Manuel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Afenjar, Karen; Fresco, Rodrigo; Severin, Irene; Ji, Yan; Ghaznawi, Farhat; Li, Zheng; Zarate, Juan P.; Chakravartty, Arunava; Taran, Tetiana; Hortobagyi, Gabriel 分享 收藏 Methodology for Good Machine Learning with Multi-Omics DataCoroller, Thibaud; Sahiner, Berkman; Amatya, Anup; Gossmann, Alexej; Karagiannis, Konstantinos; Moloney, Conor; Samala, Ravi K.; Santana-Quintero, Luis; Solovieff, Nadia; Wang, Craig; Amiri-Kordestani, Laleh; Cao, Qian; Cha, Kenny H.; Charlab, Rosane; Cross, Frank H.; Hu, Tingting; Huang, Ruihao; Kraft, Jeffrey; Krusche, Peter; Li, Yutong; Li, Zheng; Mazo, Ilya; Paul, Rahul; Schnakenberg, Susan; Serra, Paolo; Smith, Sean; Song, Chi; Su, Fei; Tiwari, Mohit; Vechery, Colin; Xiong, Xin; Zarate, Juan Pablo; Zhu, Hao; Chakravartty, Arunava; Liu, Qi; Ohlssen, David; Petrick, Nicholas; Schneider, Julie A.; Walderhaug, Mark; Zuber, Emmanuel 分享 收藏 Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancerNATALEE的基本原理和试验设计: 在HR /HER2-early乳腺癌患者中，辅助ribociclib加内分泌治疗与单独内分泌治疗的III期试验Slamon, Dennis J.; Fasching, Peter A.; Hurvitz, Sara; Chia, Stephen; Crown, John; Martin, Miguel; Barrios, Carlos H.; Bardia, Aditya; Im, Seock-Ah; Yardley, Denise A.; Untch, Michael; Huang, Chiun-Sheng; Stroyakovskiy, Daniil; Xu, Binghe; Moroose, Rebecca L.; Loi, Sherene; Visco, Frances; Bee-Munteanu, Valerie; Afenjar, Karen; Fresco, Rodrigo; Taran, Tetiana; Chakravartty, Arunava; Zarate, Juan Pablo; Lteif, Agnes; Hortobagyi, Gabriel N. 分享 收藏 Identification of mechanisms of acquired resistance to ribociclib plus endocrine therapy using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2,-3, and-7 trialsAndre, Fabrice; Solovieff, Nadia; Su, Faye; Bardia, Aditya; Neven, Patrick; Yap, Yoon-Sim; Tripathy, Debu; Lu, Yen-Shen; Slamon, Dennis; Chia, Stephen K.; Joshi, Mukta; Chakravartty, Arunava; Lteif, Agnes; Taran, Tetiana; Arteaga, Carlos 分享 收藏 Pooled gene expression analysis and association with treatment response in patients with HR+/HER2-advanced breast cancer in the MONALEESA-2,-3, and-7 trialsBardia, Aditya; Su, Faye; Solovieff, Nadia; Andre, Fabrice; Arteaga, Carlos; Neven, Patrick; Yap, Yoon-Sim; Lu, Yen-Shen; Chia, Stephen K.; Slamon, Dennis; Im, Seock-Ah; Chakravartty, Arunava; Lteif, Agnes; Taran, Tetiana; Tripathy, Debu 分享 收藏 Overall survival subgroup analysis by metastatic site from the phase 3 MONALEESA-2 study of first-line ribociclib plus letrozole in postmenopausal patients with advanced HR+/HER2-breast cancerO'Shaughnessy, Joyce; Stemmer, Salomon M.; Burris, Howard A.; Yap, Yoon-Sim; Sonke, Gabe; Hart, Lowell; Campone, Mario; Petrakova, Katarina; Winer, Eric P.; Janni, Wolfgang; Conte, Pierfranco; Cameron, David A.; Andre, Fabrice; Arteaga, Carlos; Zarate, Juan Pablo; Chakravartty, Arunava; Taran, Tetiana; Le Gac, Fabienne; Serra, Paolo; Hortobagyi, Gabriel N. 分享 收藏 Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclibTripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kummel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Kaur, Sharonjeet; Gasch, Claudia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Lu, Yen-Shen; Liu, Mei-Ching 分享 收藏 Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast CancerSlamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Sondhi, Manu; Wang, Yingbo; Chakravartty, Arunava; Rodriguez-Lorenc, Karen; Taran, Tetiana; Jerusalem, Guy 分享 收藏 分享 收藏 Overall Survival with Ribociclib plus Endocrine Therapy in Breast CancerIm, S. -A.; Lu, Y. -S.; Bardia, A.; Harbeck, N.; Colleoni, M.; Franke, F.; Chow, L.; Sohn, J.; Lee, K. -S.; Campos-Gomez, S.; Villanueva-Vazquez, R.; Jung, K. -H.; Chakravartty, A.; Hughes, G.; Gounaris, I.; Rodriguez-Lorenc, K.; Taran, T.; Hurvitz, S.; Tripathy, D. 分享 收藏 Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer (vol 76, pg 36, 2017)Massard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Mellado, Begona; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim 分享 收藏 Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancerMassard, Christophe; Chi, Kim Nguyen; Castellano, Daniel; de Bono, Johann; Gravis, Gwenaelle; Dirix, Luc; Machiels, Jean-Pascal; Mita, Alain; Gonzalez, Begona Mellado; Turri, Sabine; Maier, Joan; Csonka, Denes; Chakravartty, Arunava; Fizazi, Karim 分享 收藏 Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRudin, Charles M.; Hann, Christine L.; Garon, Edward B.; de Oliveira, Moacyr Ribeiro; Bonomi, Philip D.; Camidge, D. Ross; Chu, Quincy; Giaccone, Giuseppe; Khaira, Divis; Ramalingam, Suresh S.; Ranson, Malcolm R.; Dive, Caroline; McKeegan, Evelyn M.; Chyla, Brenda J.; Dowell, Barry L.; Chakravartty, Arunava; Nolan, Cathy E.; Rudersdorf, Niki; Busman, Todd A.; Mabry, Mack H.; Krivoshik, Andrew P.; Humerickhouse, Rod A.; Shapiro, Geoffrey I.; Gandhi, Leena 分享 收藏 Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft ModelMudd, Sarah R.; Holich, Kimberley D.; Voorbach, Martin J.; Cole, Todd B.; Reuter, David R.; Tapang, Paul; Bukofzer, Gail; Chakravartty, Arunava; Donawho, Cherrie K.; Palma, Joann P.; Fox, Gerard B.; Day, Mark; Luo, Yanping 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
CANCER RESEARCH.png)
